These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation. Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769 [TBL] [Abstract][Full Text] [Related]
4. Intravascular clotting activation and bleeding in patients with hematologic malignancies. Tallman MS; Kwaan HC Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967 [TBL] [Abstract][Full Text] [Related]
5. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies]. Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878 [TBL] [Abstract][Full Text] [Related]
6. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Barbui T; Finazzi G; Falanga A Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362 [No Abstract] [Full Text] [Related]
7. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy. Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141 [TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia. Gillis S; Dann EJ; Eldor A Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878 [No Abstract] [Full Text] [Related]
9. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment. Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837 [TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Incerpi MH; Miller DA; Posen R; Byrne JD Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337 [TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357 [TBL] [Abstract][Full Text] [Related]
12. [The effect of the recombinant thrombomodulin which merged to hematological malignancy]. Kawasugi K Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769 [No Abstract] [Full Text] [Related]
13. [Treatment of malignant hemopathies with all transretinoic acid]. Fenaux P; Chomienne C Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351 [No Abstract] [Full Text] [Related]
14. [Diagnosis and management of DIC complicated by hematological malignancies]. Ikezoe T Rinsho Ketsueki; 2016; 57(10):2136-2144. PubMed ID: 27795523 [TBL] [Abstract][Full Text] [Related]
15. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin. Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545 [No Abstract] [Full Text] [Related]
16. [Cutting edge of diagnosis and treatment of disseminated intravascular coagulation]. Seki Y Rinsho Ketsueki; 2022; 63(5):441-453. PubMed ID: 35662170 [TBL] [Abstract][Full Text] [Related]
17. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years. Kwaan HC; Cull EH Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies. Kawano N; Fukatsu M; Yamakawa K; Seki Y; Wada H; Okamoto K; Ikezoe T Int J Hematol; 2024 Apr; 119(4):416-425. PubMed ID: 38270783 [TBL] [Abstract][Full Text] [Related]
19. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia. Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226 [No Abstract] [Full Text] [Related] [Next] [New Search]